John M. Ashton
- Molecular Biology top 5%
- Hematology top 0.5%
- Cancer Research top 2%
- Oncology top 5%
- Immunology top 10%
- Co-authors
- Craig T. JordanMichael W. BeckerMohammad MinhajuddinShanshan PeiJane L. LiesveldSarah J. NeeringKristen M. O’DwyerRandall M. Rossi
- Topics
- Acute Myeloid Leukemia Research (21 papers)Hematopoietic Stem Cell Transplantation (8 papers)Mesenchymal stem cell research (7 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
John M. Ashton
60 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Biology 2.0k
- Hematology 1.3k
- Cancer Research 834
- Oncology 507
- Immunology 420
Countries citing papers authored by John M. Ashton
This map shows the geographic impact of John M. Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Ashton more than expected).
Fields of papers citing papers by John M. Ashton
This network shows the impact of papers produced by John M. Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Ashton. The network helps show where John M. Ashton may publish in the future.
Co-authorship network of co-authors of John M. Ashton
This figure shows the co-authorship network connecting the top 25 collaborators of John M. Ashton. A scholar is included among the top collaborators of John M. Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Ashton. John M. Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 22 | |
| 6 | 29 | |
| 7 | 93 | |
| 8 | 25 | |
| 9 | 71 | |
| 10 | Single-Cell Genomics: Best Practices and New Insights | 1 |
| 11 | 55 | |
| 12 | 1 | |
| 13 | 72 | |
| 14 | 48 | |
| 15 | 20 | |
| 16 | 166 | |
| 17 | 33 | |
| 18 | BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cellsbreakdown → | 943 |
| 19 | 45 | |
| 20 | 35 |
About John M. Ashton
John M. Ashton is a scholar working on Hematology, Genetics and Cancer Research, having authored 62 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Mesenchymal stem cell research (7 papers). The work is most often cited by research in Hematology (1.3k citations), Cancer Research (834 citations) and Molecular Biology (2.0k citations). John M. Ashton has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Craig T. Jordan, Michael W. Becker, Mohammad Minhajuddin, Shanshan Pei, Jane L. Liesveld, Sarah J. Neering, Kristen M. O’Dwyer, Randall M. Rossi, Jason R. Myers and Paul S. Brookes. Their work appears in journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.